Position Paper on Critical Care Pharmacy Services (Executive
Summary): 2020 Update
by Lat, Ishaq; Paciullo, Christopher; Daley, Mitchell J.;
MacLaren, Robert; Bolesta, Scott; McCann, Jennifer; Stollings, Joanna L.;
Gross, Kendall; Foos, Sarah A.; Roberts, Russel J.; Acquisto, Nicole M.;
Taylor, Scott; Bentley, Michael; Jacobi, Judith; Meyer, Tricia A.
Critical Care Medicine: September
2020 - Volume 48 - Issue 9 - p 1375-1382
Objectives:
Provide a multiorganizational statement to update the
statement from a paper in 2000 about critical care pharmacy practice
and makes recommendations for future practice.
Design:
The Society of Critical Care Medicine, American
College of Clinical Pharmacy Critical Care Practice and Research
Network, and the American Society of Health-Systems Pharmacists convened a
joint task force of 15 pharmacists representing a broad cross-section of critical
care pharmacy practice and pharmacy administration,
inclusive of geography, critical care practice setting, and roles.
The Task Force chairs reviewed and organized primary literature, outlined topic
domains, and prepared the methodology for group review and consensus. A
modified Delphi method was used until consensus (> 66% agreement) was
reached for each practice recommendation. Previous position statement
recommendations were reviewed and voted to either retain, revise, or retire.
Recommendations were categorized by level of ICU service to be applicable by
setting, and grouped into five domains: patient care, quality improvement,
research and scholarship, training and education, and professional
development.
Main Results:
There are 82 recommendation statements: forty-four original
recommendations and 38 new recommendation statements. Thirty-four
recommendations were made for patient care, primarily relating to critical
care pharmacist duties and pharmacy services. In the quality
improvement domain, 21 recommendations address the role of the critical
care pharmacist in patient and medication safety, clinical quality
programs, and analytics. Nine recommendations were made in the domain of
research and scholarship. Ten recommendations are in the domain of training and
education and eight recommendations regarding professional development.
Conclusions:
The statements recommended by this taskforce delineate the
activities of a critical care pharmacist and the scope of pharmacy services
within the ICU. Effort should be made from all stakeholders to implement the
recommendations provided, with continuous effort toward improving the delivery
of care for critically ill patients.
